CHICAGO (CBS)– Pfizer announced its COVID-19 vaccine protects children as young as 12 years old.
For the first time, this could open the door for expanded use of the vaccine in children by the fall.READ MORE: Family Escapes House Fire In Brighton Park
“The Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old, and was well tolerated,” Pfizer reported Wednesday morning.READ MORE: Protesters Pack Logan Square Over Police Shooting Of Adam Toledo
In a study of 2,260 U.S. volunteers aged 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given placebo shots, Pfizer reported.MORE NEWS: Chicago Weather: Rising Temperatures Through The Weekend But Snow Possible Next Week
CBS News reported results also are expected soon from a U.S. study of Moderna’s vaccine in 12- to 17-year-olds.